4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole, 97.0%, 5g

4-(Tetrahydropyran-4-yl)-pyridine, 1g

1,7-Dibromoheptane, 95.0%, 100g

2-[4-(2-hydroxyethyl)-1-piperazinyl]acetamide hydrochloride, 95.0%, 5g

2-[4-[(4-CHLOROPHENYL)-PHENYLMETHYL]PIPERAZIN-1-YL]ETHANOL, 95.0%, 1g

4-((1R,2R)-3-(4-BENZYLPIPERIDIN-1-YL)-1-HYDROXY-2-METHYLPROPYL)PHENOL, 97%, 50mg

3-(2-chlorophenyl)prop-2-ynoic acid, 95.0%, 500mg

BENZYL 4-(OXETAN-3-YL)PIPERAZINE-1-CARBOXYLATE, 95.0%, 25g

5-(3,4,5-triethoxyphenyl)-1,3,4-oxadiazol-2-amine, 95.0%, 250mg

1-(4-Benzhydryl-piperazin-1-yl)-2-chloro-ethanone, 98%, 5g

1-Bromo-4-[(iso-propyloxy)methyl]benzene, 97.0%, 100mg

2,4-Dihydroxy-6-methylpyridine>98.0%(GC)(T)5g

Solución estándar de paladio ICP, ROTI®Star, 250 ml, LDPE